Abstract:(1) Background: Toad venom (Bufonis Venenum, known as 'Chansu' in Chinese), the secretion of the ear-side gland and skin gland of Bufo gargarizans cantor or Duttaphrynus melanostictus Schneider, has been utilized to treat several diseases in China for thousands of years. However, due to the chemical variability of the components, systematic chemical composition and the key pharmacophores in toad venom have not yet fully understood. Besides, it contains a variety of effective compounds with different physiological activity and chemotypes, mainly including alkaloids, bufogenins, bufotoxins, and so on. The recent pharmacological researches have demonstrated that several bufogenins have remarkable pharmacological effects, such as anti-inflammatory, analgesic effects, and anti-tumor effects. Aim of the study: To identify the bioactive compounds and pharmacophores originating from toad venom based on analyzing spectrum-effect relationship by chemometrics and to explore the anti-cancer mechanism primarily. (2) Materials and methods: Fingerprint of the 21 batches of samples was established using HPLC (High Performance Liquid Chromatography). The anti-tumor activity of extracts were determined by in-vitro assays. Chemometric analysis was used to establish the spectrum-effect model and screen for active ingredients. Pharmacodynamic tests for the screened active compound monomers were conducted with in-vitro assays. Further anti-tumor mechanisms were investigated using western blot and flow cytometry. (3) Results: The established spectrum-effect model has satisfactory fitting effect and predicting accuracy. The inhibitory effect of major screened compounds on lung carcinoma cells A549 were validated in vitro, demonstrating that arenobufagin, telocinobufogenin, and cinobufotalin had significant anti-tumor effects. Through further investigation of the mechanism by western blotting and flow cytometry, we elucidated that arenobufagin induces apoptosis in A549 cells with the enhanced expression of cleaved PARP (poly (ADP-ribose) polymerase). These results may provide valuable information for further structural modification of bufadienolides to treat lung cancer and a method for discovery of anti-tumor active compounds. Conclusions: Our research offers a more scientific method for screening the principal ingredients dominating the pharmacodynamic function. These screened compounds (arenobufagin, etc.) were proven to induce apoptosis by overactivation of the PARP-pathway, which may be utilized to make BRCA (breast cancer susceptibility gene) mutant cancer cells more vulnerable to DNA damaging agents and kill them.

Tunable Toxicity of Bufadienolides is Regulated Through a Configuration Inversion Catalyzed by a Short-Chain Dehydrogenase/Reductase

3α-Hydroxybufadienolides in Bufo gallbladders: structural insights and biotransformation

Cytochrome P450 Mining for Bufadienolide Diversification

Lipidomics Combined with Transcriptomic and Mass Spectrometry Imaging Analysis of the Asiatic Toad (bufo Gargarizans) During Metamorphosis and Bufadienolide Accumulation.

Bufadienolide-Fatty Acid Conjugates from the Fertilized Eggs of Toad Bufo gargarizans: Isolation, Characterization, Toxicity, and Antiproliferative Evaluation

Bufadienolides originated from toad source and their anti-inflammatory activity

Chemical Profiling and Cytotoxicity Assay of Bufadienolides in Toad Venom and Toad Skin.

Identification of Antitumor Constituents in Toad Venom by Spectrum-Effect Relationship Analysis and Investigation on Its Pharmacologic Mechanism

An Efficient Strategy Based on Liquid-Liquid Extraction with Three-Phase Solvent System and High Speed Counter-Current Chromatography for Rapid Enrichment and Separation of Epimers of Minor Bufadienolide from Toad Meat

Isolation and Identification of L/d-Lactate-conjugated Bufadienolides from Toad Eggs Revealing Lactate Racemization in Amphibians.

Anti-tumor Effects and 3D-Quantitative Structure-Activity Relationship Analysis of Bufadienolides from Toad Venom.

Substrate specificity for the 12beta-hydroxylation of bufadienolides by Alternaria alternata.

Systematic Screening and Characterization of Novel Bufadienolides from Toad Skin Using Ultra-Performance Liquid Chromatography/Electrospray Ionization Quadrupole Time-Of-Flight Mass Spectrometry

Study of Bufogenins on Sulfonation Reaction and Enrichment of Sulfated Bufogenins via a Homemade RP/HILIC-SPE

Screening of Bufadienolides from Toad Venom Identifies Gammabufotalin as a Potential Anti-inflammatory Agent

Metabolites Profiling of 10 Bufadienolides in Human Liver Microsomes and Their Cytotoxicity Variation in HepG2 Cell.

Isolation, Identification and Chemical Modification of Bufadienolides from Bufo melanostictus Schneider and Their Cytotoxic Activities against Prostate Cancer Cells

A new bufadienolide from Bufo gargarizans Cantor

Stereoselective toxicity: Investigating the adverse effects of benzovindiflupyr on Xenopus laevis tadpoles

New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus

Highly selective isomerization and dehydrogenation of three major bufadienolides at 3-OH by Fusarium solani